ASCO对ASTRO小细胞肺癌放疗指南的背书
ASCO专家小组对ASTRO于2020年6月发布的小细胞肺癌放疗指南进行方法学严谨性审查和内容评议,认定其推荐清晰、全面且基于最相关科学证据,予以背书并附少量讨论点。推荐涵盖局限期胸部放疗、I/II期淋巴结阴性SCLC的立体定向放疗、预防性颅脑照射及广泛期胸部巩固放疗。
要点
- ASCO背书ASTRO小细胞肺癌放疗指南,推荐清晰全面。
- 推荐覆盖局限期胸部放疗和广泛期胸部巩固放疗。
- 涉及I/II期淋巴结阴性SCLC的立体定向放疗及预防性颅脑照射。
核心结论
- ASCO专家小组认定ASTRO小细胞肺癌放疗指南推荐清晰、全面且基于最相关科学证据,予以背书并附少量讨论点。
研究设计与样本
- ASCO方法学家审查ASTRO指南制定严谨性,再由ASCO专家小组评议内容和推荐。
主要发现
- ASCO专家小组确定ASTRO于2020年6月发布的小细胞肺癌放疗指南推荐清晰、全面且基于最相关科学证据。
关键数值与推荐
- 推荐涉及局限期SCLC的胸部放疗。
- 推荐涉及I期或II期淋巴结阴性SCLC中立体定向体部放疗的作用。
- 推荐涉及预防性颅脑放疗。
- 推荐涉及广泛期SCLC的胸部巩固放疗。
临床怎么用
- 肿瘤内科医生可参照ASCO背书的ASTRO指南,对局限期和广泛期SCLC的放疗决策进行规范。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: The American Society for Radiation Oncology (ASTRO) produced an evidence-based guideline on radiation therapy (RT) for small-cell lung cancer (SCLC). Because of the relevance of this topic to ASCO membership, ASCO reviewed the guideline, applying a set of procedures and policies used to critically examine guidelines developed by other organizations. METHODS: The ASTRO guideline on RT for SCLC was reviewed for developmental rigor by methodologists. Then, an ASCO Expert Panel reviewed the content and the recommendations. RESULTS: The ASCO Expert Panel determined that the recommendations from ASTRO guideline on RT for SCLC, published in June 2020, are clear, thorough, and based upon the most relevant scientific evidence. ASCO endorsed ASTRO guideline on RT for SCLC with a few discussion points. RECOMMENDATIONS: Recommendations addressed thoracic radiotherapy for limited-stage SCLC, role of stereotactic body radiotherapy in stage I or II node-negative SCLC, prophylactic cranial radiotherapy, and thoracic consolidation for extensive-stage SCLC.Additional information is available at www.asco.org/thoracic-cancer-guidelines.
引用
- Daly ME, Ismaila N, Decker RH, et al. Radiation Therapy for Small-Cell Lung Cancer: ASCO Guideline Endorsement of an ASTRO Guideline. J Clin Oncol. 2021. PMID: 33502911. doi:10.1200/JCO.20.03364
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。